Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1996 | 12-1995 | 09-1995 | 06-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,813 | 1,888 | 2,348 | N/A | N/A |
| Receivables | N/A | 48 | 12 | N/A | N/A |
| Other current assets | 65 | 193 | 25 | 0 | 0 |
| TOTAL | $6,878 | $2,129 | $2,385 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 559 | N/A | 95 | N/A | N/A |
| TOTAL | $559 | $N/A | $95 | $N/A | $N/A |
| Total Assets | $7,230 | $2,129 | $2,417 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 136 | 0 | 0 | 0 |
| Accrued Expenses | N/A | 227 | N/A | N/A | N/A |
| Other current liabilities | N/A | 73 | N/A | N/A | N/A |
| TOTAL | $459 | $436 | $199 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 7 | N/A | N/A | N/A |
| TOTAL | $N/A | $7 | $N/A | $N/A | $N/A |
| Total Liabilities | $459 | $443 | $199 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1,252 | 350 | 350 | N/A | N/A |
| Retained earnings | N/A | -39,026 | N/A | N/A | N/A |
| Other shareholders' equity | 5,219 | -5 | 1,858 | 0 | 0 |
| TOTAL | $6,471 | $1,686 | $2,208 | $N/A | $N/A |
| Total Liabilities And Equity | $6,930 | $2,129 | $2,407 | $0 | $0 |